Table 3. In Vitro Antimicrobial Activity of the Isolated Compounds.
| strain | 1 | 2 | 3 | 4 | 5 | |
|---|---|---|---|---|---|---|
| M. smegmatis MIC (μM) | 158.2 | 39.4 | >100 | >100 | >100 | |
| Mtb mc2 6220 BSL2 growth inhibition (%) | 0 | 70 at 6.25 μM | NTa | NT | NT | |
| Mtb mc2 6220 BSL2MIC (μM) | NT | 12.5 | NT | NT | NT | |
| Mtb H37Rv MIC (μM) | NT | >100 | NT | NT | NT | |
| E. coli MIC (μM) | 39.6 | 157.5 | >100 | >100 | >100 | |
| Staphylococcus aureus MIC (μM) | 9.9 | 39.4 | >100 | >100 | >100 | |
| MRSA MIC (μM) | strain 1 | 9.9 | 39.4 | NT | NT | NT |
| strain 2 | 39.6 | 39.4 | NT | NT | NT | |
| strain 3 | 39.6 | 19.7 | NT | NT | NT | |
| strain 4 | 9.9 | 39.4 | NT | NT | NT | |
| strain 5 | 9.9 | 19.7 | NT | NT | NT | |
a
NT: not tested.